These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proceedings: The efferent pathway of the reflex increase in heart rate produced by stimulation of left arterial receptors. Kappagoda CT, Linden RJ, Scott EM, Snow HM. J Physiol; 1974 Oct; 242(2):79P-80P. PubMed ID: 4156368 [No Abstract] [Full Text] [Related]
4. Assessment of beta-blocking activity of trimepranol in man. Pentikäinen PJ, Neuvonen PJ, Penttilä A. Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464 [Abstract] [Full Text] [Related]
5. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol. Regardh CG, Ablad B, Borg KO, Johnsson G, Solvell L. Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405 [No Abstract] [Full Text] [Related]
12. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig. Horii D, Kawada T, Takeda K, Imai S. Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764 [No Abstract] [Full Text] [Related]
13. Comparison of the effects of propranolol and ICI 66082 in blocking the renin releasing effect of renal nerve stimulation in the cat. Johns EJ, Singer B. Br J Pharmacol; 1974 Oct; 52(2):315-8. PubMed ID: 4155994 [Abstract] [Full Text] [Related]
14. Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032). Aberg H. Int J Clin Pharmacol; 1974 Mar; 9(2):98-100. PubMed ID: 4151244 [No Abstract] [Full Text] [Related]
15. Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline. Johnsson G, Nyberg G, Sölvell L. Acta Pharmacol Toxicol (Copenh); 1975 Mar; 36(Suppl 5):69-75. PubMed ID: 1094803 [No Abstract] [Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol. Vinceneux P, Canal M, Domart Y, Roux A, Cascio B, Orofiamma B, Larribaud J, Flouvat B, Carbon C. Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990 [Abstract] [Full Text] [Related]
17. Prediction of the non-specific cardiodepressant effects of beta-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis. Hellenbrecht D, Grobecker H, Müller KF. Eur J Pharmacol; 1974 Dec; 29(2):223-5. PubMed ID: 4155366 [No Abstract] [Full Text] [Related]
18. Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3',5'-monophosphate and DNA synthesis during liver regeneration. MacManus JP, Braceland BM, Youdale T, Whitfield JF. J Cell Physiol; 1973 Oct; 82(2):157-64. PubMed ID: 4148138 [No Abstract] [Full Text] [Related]
19. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade. Mylecharane EJ, Raper C. Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862 [No Abstract] [Full Text] [Related]
20. A comparison of the effects of propranolol and practolol on forced expiratory volume and resting heart rate in normal subjects. Turner P, Burman J, Hicks DC, Cherrington NK, MacKinnon J, Wallet T, Woolnough M. Arch Int Pharmacodyn Ther; 1971 May; 191(1):104-10. PubMed ID: 4397623 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]